SIGHT SCIENCES, INC. Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount
SIGHT SCIENCES, INC. (SGHT) reported Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount of 8.18 million shares for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount · last filed 2026-08-05
- SIGHT SCIENCES, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2026-03-31 was 8.62M shares, a 18.08% decline year-over-year.
- SIGHT SCIENCES, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-03-31 was 10.52M shares, a 5.71% increase year-over-year.
- SIGHT SCIENCES, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2024-03-31 was 9.95M shares, a 43.49% increase year-over-year.
- SIGHT SCIENCES, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2023-03-31 was 6.94M shares, a 5.07% increase year-over-year.
- SIGHT SCIENCES, INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2025 was 7.27M shares, a 18.89% decline from fiscal 2024.
- SIGHT SCIENCES, INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2024 was 8.97M shares, a 16.44% increase from fiscal 2023.
- SIGHT SCIENCES, INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2023 was 7.70M shares, a 32.01% increase from fiscal 2022.
- SIGHT SCIENCES, INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2022 was 5.83M shares, a 15.52% increase from fiscal 2021.
| Period end | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month |
|---|---|---|---|---|
| 2026-06-30 | 8.18M shares 10-Q · filed 2026-08-05 | |||
| 2026-03-31 | 8.62M shares 10-Q · filed 2026-05-06 | |||
| 2025-12-31 | 7.27M shares 10-K · filed 2026-03-04 | |||
| 2025-09-30 | 8.39M shares 10-Q · filed 2025-11-06 | |||
| 2025-06-30 | 10.23M shares 10-Q · filed 2026-08-05 | |||
| 2025-03-31 | 10.52M shares 10-Q · filed 2026-05-06 | |||
| 2024-12-31 | 8.97M shares 10-K · filed 2026-03-04 | |||
| 2024-09-30 | 9.29M shares 10-Q · filed 2025-11-06 | |||
| 2024-06-30 | 9.60M shares 10-Q · filed 2025-08-07 | |||
| 2024-03-31 | 9.95M shares 10-Q · filed 2025-05-08 | |||
| 2023-12-31 | 7.70M shares 10-K · filed 2025-03-07 | |||
| 2023-09-30 | 6.56M shares 10-Q · filed 2024-11-07 | |||
| 2023-06-30 | 6.78M shares 10-Q · filed 2024-08-02 | |||
| 2023-03-31 | 6.94M shares 10-Q · filed 2024-05-06 | |||
| 2022-12-31 | 5.83M shares 10-K · filed 2024-03-13 | |||
| 2022-09-30 | 5.73M shares 10-Q · filed 2023-11-07 | |||
| 2022-06-30 | 6.48M shares 10-Q · filed 2023-08-07 | |||
| 2022-03-31 | 6.60M shares 10-Q · filed 2023-05-08 | |||
| 2021-12-31 | 5.05M shares 10-K · filed 2023-03-16 | |||
| 2021-09-30 | 5.25M shares 10-Q · filed 2022-11-10 | |||
| 2021-06-30 | 18.28M shares 10-Q · filed 2022-08-11 | |||
| 2021-03-31 | 16.41M shares 10-Q · filed 2022-05-10 | |||
| 2020-12-31 | 16.23M shares 10-K · filed 2022-03-24 | |||
| 2020-09-30 | 14.90M shares 10-Q · filed 2021-11-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NeuroPace Inc (NPCE) | United States | $0.480B | -28.52 |
| ClearPoint Neuro, Inc. (CLPT) | United States | $0.446B | -15.74 |
| TACTILE SYSTEMS TECHNOLOGY INC (TCMD) | United States | $0.519B | 27.16 |
| CERUS CORP (CERS) | United States | $0.525B | -86.40 |
| CARLSMED, INC. (CARL) | United States | $0.405B | |
| DELCATH SYSTEMS, INC. (DCTH) | United States | $0.558B | 820.33 |
| Orthofix Medical Inc. (OFIX) | $0.373B | ||
| SS Innovations International, Inc. (SSII) | $0.589B | -64.06 | |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B | |
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |